OOIR: Observatory of International Research

Papers

(The H4-Index of International Journal of Radiation Oncology Biology Physics is 45. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)

Article	Citations
Issue Highlights page	156
Careful with the Cauda	140
Managing the Minefields in Optimal Treatment	138
Issue Highlights page	137
Prognostic Factors of Mandibular Osteoradionecrosis Including Accurate Colocalization of Avulsions and Dosimetric Dental Mapping Software, a Case-control Study	102
Evidence for Persistent Radiation-Related Injury to the Immune System in Patients With Local Breast Cancer	98
Radiation Dose-Volume-Response Relationships for Adverse Events in Childhood Cancer Survivors: Introduction to the Scientific Issues in PENTEC	89
Does Operability Status Influence Outcomes in Patients with T4 Larynx Cancer Undergoing Larynx Preservation?	88
The R's of Radiation Therapy: Do We Need More or Do We Move On?	86
A Pilot Study of Head and Neck Cancer Patients Treated Daily with an Intraoral Photobiomodulation (PBM) Device while Undergoing IMRT Demonstrates Tolerability, Safety, and Preliminary Efficacy for Red	82
The Irradiated Brain Volume Within 12 Gy Is a Predictor for Radiation-Induced Changes After Stereotactic Radiosurgery in Patients With Unruptured Cerebral Arteriovenous Malformations	78
Pre-Clinical Validation of Targeting Cholesterol Metabolism for Radiotherapy Sensitization in Head and Neck Cancer	74
A National Cancer Disparities Analysis of Pacific Islanders Who Decline Radiation Therapy and Impacts on Overall Survival	72
A Crowdsourcing Challenge for the Development of Artificial Intelligence Algorithms for Automated Identification and Delineation of Pancreatic Cancer Primary Tumors	71
Organ at Risk Dose Constraints in Stereotactic Ablative Radiotherapy: A Systematic Review of Active Clinical Trials	71
Prospective Longitudinal Assessment of Quality of Life after Stereotactic Ablative Radiotherapy for Oligometastases: Analysis of the Population-Based SABR-5 Phase II Trial	69
Combination of Radiotherapy and Atezolizumab plus Bevacizumab in Patients with Advanced Hepatocellular Carcinoma: A Pilot Study	69
Salvage Ablative Radiation Therapy for Isolated Intraabdominal Recurrences of Hepatocellular Carcinoma	67
Synthetic CT Generation From Multi-Sequence MR Images for Head and Neck MRI-Only Radiotherapy via Cycle-Consistent Generative Adversarial Network	66
MR-Guided Radiotherapy (MRgRT) for Laryngeal Cancer With Real-Time Visualization of Intrafraction Larynx Motion	65
Wireless Device for Adaptive Planning Based Upon Thermoacoustic Range Estimates ― Design and Benchtop Validation	64
Disease-Free Survival of Patients with Muscle Invasive Bladder Cancer Treated by Radical Cystectomy vs. Bladder-Sparing Therapy at a Nationwide Level	62
Sarcopenia as a Predictor of Neoadjuvant Therapy-Related Toxicity in Esophageal Squamous Cell Carcinoma Patients	60
Improving Interpretability of Machine Learning in Head and Neck Radiation Therapy Pretreatment Physics Plan Reviews	60
Withdrawn	59

Evaluation of Patient and Tumor Features to Optimize Urothelial Metastasis Treatment	57
Real Time Volumetric MRI for MR-Guided 3D Motion Tracking via Sparse Prior-Augmented Neural Representation Learning	56
Stereotactic Ablative Radiotherapy for the Treatment of Pancreatic Metastases from Renal Cell Carcinoma	56
Multitask AI Models for the Joint Prediction of Overall Survival, Progression-Free Survival, and Death without Progression as a Composite Endpoint for LA-NSCLC Patients Treated with Chemoradiotherapy	56
Patient Factors Associated With Loss to Radiation Oncology Specialty Follow-Up Among Head and Neck Cancer Survivors	55
Combined Brachytherapy and Ultra-Hypofractionated Radiotherapy for Intermediate-Risk Prostate Cancer: Comparison of Toxicity Outcomes Using a High-Dose Rate (HDR) vs. Low-Dose Rate (LDR) Brachytherapy	55
Vertex Position Optimization for LATTICE Therapy	54
Rapid Reinstatement of Cancer Care after Hurricane Ian	53
The Utility of Mean Apparent Diffusion Coefficient Value in Patients with Prostate Cancer Treated with Definitive Radiotherapy	52
Predictors of Interstitial Brachytherapy Utilization in Locally Advanced Cervical Cancer and Impact on Overall Survival	51
Perineural Invasion Combined with Pattern C of the Silva Classification System Correlates Poor Prognosis in Cervical Adenocarcinoma Following a Radical Hysterectomy	50
International Clinical Radiotherapy Audit in CCCN- iPAAC Project	50
Incidence of Major Depression, Suicidal Ideation, and Mental Health Treatment Amongst Cancer Survivors	48
Single Fraction HDR Brachytherapy for Prostate Cancer: SiFEPI Phase II Trial Results	47
Deep Learning-Based Automatic Delineation of Target Volumes and Organs at Risk of Breast Cancer for On-Line Dosimetric Evaluation	47
Brain Metastases in Metastatic Cutaneous Melanoma: Patterns of Care and Clinical Outcomes in the Era of Immunotherapy and Targeted Therapy	47
1.5T MR-Guided Daily Adaptive Radiotherapy: Preliminary Clinical Report of the First 5000 Fractions	47
Dosimetric Comparison and Clinical Implications of Dose Calculation Algorithms for Stereotactic Body Radiation Therapy in Spine Metastases	46
Withdrawn	46
The Role and Mechanism of Ferroptosis Mediated by METTL3-m6A Modification in Regulating Radioresistance of Esophageal Cancer	45
Dosimetric Outcomes for Multiple Intracranial Targets Treated Simultaneously With LINAC-Based Stereotactic Radiosurgery as Dictated by Beam Energy, MLC Leaf Width, and Prescribed Isodose Level	45
How the Underlying Etiology of Cirrhosis Impacts Response to SBRT	45
The Universality of Parallel Increasing Quantitative Nodal Burden and Mortality Across Solid Cancers	45